Rapid molecular diagnostics for multi-drug resistant tuberculosis in India

References

• Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 24(11):1005–1015.
   Google Scholar
• Ehsani S, Van den Boom M, Gilpin C, et al. The role of novel molecular techniques for tuberculosis diagnostics in the WHO European region. J Med Microb Diagn 2015; S3: 006.
   Google Scholar
• World Health Organisation. Rapid implementation of the Xpert MTB/RIF diagnosis test. Technical and operational “How to” practical considerations. World Health Organization; WHO/HTM/TB/20112. WHO, Geneva, 2014.
   Google Scholar
• World Health Organisation. Global Tuberculosis Report 2017. Geneva: World Health Organization; 2017.
   Google Scholar
• World Health Organisation. WHO/global fund workshop reaching the “missing million” through scaling up public-private mix for TB care and control in “high-impact”. Asia Meeting Report, WHO/HTM/TB/2014.25; 2014 Jun 25–27; New Delhi, India.
   Google Scholar
• Central TB Division. 2017. TB India. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi.
   Google Scholar
• Jain A, Singh PK, Chooramani G, et al. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India. Int J Tuberc Lung Dis 2016; 20(7):870–875.
   PubMed Web of Science ®Google Scholar
• Gilpin C, Korobitsyn A, Weyer K, et al. Current tools available for the diagnosis of drug-resistant tuberculosis. Ther Adv Infect Dis 2016, Vol. 3(6) 145–151
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Xpert MTB/RIF assay for diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update. WHO/HTM/TB/2013.16. Geneva: World Health Organization; 2013.
   Google Scholar
• Steingart KR, Schiller I, Horne DJ, et al. Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014 Jan 21; (1): 1–166.
   Google Scholar
• Lawn SD, Zumla AI. Diagnosis of extrapulmonary tuberculosis using the Xpert® MTB/RIF assay. Expert Rev Anti Infect Ther. 2012 Jun; 10(6): 631–635.
   PubMed Web of Science ®Google Scholar
• Kambli P, Ajbani K, Sadani M, et al. Defining multidrug-resistant tuberculosis: Correlating genotype MTBDRplus assay results with minimum inhibitory concentrations. Diagn Microbiol Infect Dis 2015;82(1):49–53.
   Google Scholar
• World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis. Geneva: WHO, 2016
   Google Scholar
• Nair D, Navneethapandian PD, Tripathy JP, et al. Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India. Trans R Soc Trop Med Hyg 2016; 110(9): 534–541.
   PubMed Web of Science ®Google Scholar
• Singh UB, Pandey P, Mehta G, et al. (2016) Genotypic, phenotypic and clinical validation of GeneXpert in extra-pulmonary and pulmonary tuberculosis in India. PLoS ONE 11(2): e0149258.
   PubMed Web of Science ®Google Scholar
• Rufail SB, Singh S, Singh A, et al. Performance of Xpert MTB/RIF on ascitic fluid samples for detection of abdominal tuberculosis. J Lab Physicians. 2017 Jan-Mar; 9(1): 47–52.
   PubMedGoogle Scholar
• Schumacher SG, Nabeta P, Boehme CC, et al. A multicenter diagnostic accuracy study of the Xpert Ultra for tuberculosis diagnosis. Conference Retroviruses Oppor Infect; 2017 Feb 13–16; Seattle, WA.
   Google Scholar
• Nair C Overview of technological platforms: Molbio. Oral presentation at: Critical Path to TB Drug Regimens Workshop; 2016 Apr 4–7; Washington, DC.
   Google Scholar
• Nikam C, Kazi M, Nair C, et al. Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis. Int J Mycobacteriol. 2014 Sep;3(3):205–210. doi: 10.1016/j.ijmyco.2014.04.003
   PubMedGoogle Scholar
• Erica Lessem. The tuberculosis diagnostics pipeline. Treatment Action Group; 2017. (Pipeline report).
   Google Scholar
• Tomasicchio M, Theron G, Pietersen E, et al. The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates. Sci Rep 2016; (6): 17850.
   PubMed Web of Science ®Google Scholar
• Raizada N, Sachdeva KS, Chauhan DS, et al. A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens. PLoS ONE 2014; 9(2):e88626. DOI:10.1371/journal.pone.0088626
   PubMed Web of Science ®Google Scholar
• Sharma SK, Kohli M, Yadav RN, et al. (2015) Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PLoS ONE 10(10): e0141011. doi:10.1371/journal.pone.0141011
   PubMed Web of Science ®Google Scholar
• Manson AL, Abeel T, Galagan JE, et al. Mycobacterium tuberculosis whole genome sequences from Southern India suggest novel resistance mechanisms and the need for region specific diagnostics. Clin Infect Dis 2017;64(11):1494–1501.
   PubMed Web of Science ®Google Scholar
• Singla N, Satyanarayana S, Sachdeva KS, et al. Impact of introducing the line probe assay on time to treatment initiation of MDR-TB in Delhi, India. PLoS ONE 2014; 9(7): e102989.
   PubMed Web of Science ®Google Scholar
• Yacoob FL, Jose BP, Devi S, et al. 2016d. Primary multidrug resistant tuberculosis and utility of line probe assay for its detection in smear-positive sputum samples in a tertiary care hospital in South India. J Pathog 2016; ID 6235618, 8. https://www.hindawi.com/journals/jpath/2016/6235618/
   Google Scholar
• Arora J, Singhal R, Bhalla M, et al. Drug resistance detection and mutation patterns of multidrug resistant tuberculosis strains from children in Delhi. J Epidemiol Glob Health 2016; 7(2):141–145.
   Web of Science ®Google Scholar
• Bhirud P, Joshi A, Hirani N, et al. Rapid laboratory diagnosis of pulmonary tuberculosis. Int J Mycobacteriol 2017; 3(3): 296–301.
   Google Scholar
• Catanzaro A, Rodwell TC, Catanzaro DG, et al. Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis. PLoS ONE 2015; 10(8): e0136861. doi:10.1371/journal.pone.0136861.
   PubMed Web of Science ®Google Scholar
• Dave P, Patel P, Mod B, et al. Evaluation of use of line probe assay on smear-positive direct specimen from extra-pulmonary tuberculosis site. Indian J Tuberc 2015; 62(4): 218–221.
   PubMedGoogle Scholar
• Kumar P, Balooni V, Sharma BK, et al. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. Tuberculosis (Edinb) 2013; 94 (1): 73–80.
   PubMed Web of Science ®Google Scholar
• Kumar P, Balooni V, Singh S. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India. Int J Tuberc Lung Dis 2015; 19(4): 434–439.
   PubMed Web of Science ®Google Scholar
• Madhuri K, Deshpande S, Dharmashale S, et al. Utility of line probe assay for the early detection of multidrug-resistant pulmonary tuberculosis. J Glob Infect Dis 2015; 7(2): 60–65.
   PubMed Web of Science ®Google Scholar
• Singhal R, Myneedu VP, Arora J, et al. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from north-eastern states of India using GenoType MTBDRplus assay. Indian J Med Res 2014; 140(4): 501–506.
   PubMedGoogle Scholar
• Singhal R, Singla N, Myneedu VP, et al. Multidrug-resistant tuberculosis among different types of suspected cases: study from New Delhi. Indian J Tuberc 2015; 62 (3): 183–186.
   PubMedGoogle Scholar
• Tripathi R, Anupurba S Multidrug-resistant tuberculosis detection and characterization of mutations in mycobacterium tuberculosis by genotype MTBDRplus. Indian J Pathol Microbiol 2017; 60(2):239–242.
   PubMed Web of Science ®Google Scholar
• Tripathi R, Sinha P, Kumari R, et al. Detection of rifampicin resistance in tuberculosis by molecular methods: a report from eastern Uttar Pradesh, India. Indian J Med Microbiol 2016;34:92–94
   PubMed Web of Science ®Google Scholar
• Tripathy S, Kumar R, Singh D. Prevalence of multidrug resistant pulmonary tuberculosis in north Bihar. J Clin Diagn Res 2015; 9(11): LC09–LC12.
   PubMed Web of Science ®Google Scholar
• Vashistha H, Hanif M, Saini S, et al. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India. Indian J Tuberc 2016; 63(3): 144–148.
   PubMedGoogle Scholar
• Sharma SK, Chaubey J, Singh BK, et al. Drug resistance patterns among extra-pulmonary tuberculosiscases in a tertiary care centre in North India. Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1112–1117. doi: 10.5588/ijtld.16.0939
   PubMed Web of Science ®Google Scholar
• Kaviyil JE, Ravikumar R. Diagnosis of tuberculous meningitis: current scenario from a tertiary neurocare centre in India. Indian J Tuberc 2017; 64(3):183–188. Epub 2017. doi: 10.1016/j.ijtb.2017.01.005.
   PubMedGoogle Scholar
• Desikan P, Panwalkar N, Mirza SB, et al. Line probe assay for detection of Mycobacterium tuberculosis complex: an experience from Central India. Indian J Med Res 2017; 145: 70–73.
   PubMed Web of Science ®Google Scholar
• World Health Organsiation. Molecular line-probe assay for the detection of resistance to Second-Line Anti-Tb Drugs (SL-LPA). World Health Organsiation, Geneva, Switzerland; 2016; http://www.who.int/tb/publications/factsheet_tb_sllpa.pdf
   Google Scholar
• World Health Organization. Tuberculosis laboratory biosafety manual 2012. World Health Organization, Geneva, Switzerland. . WHO/HTM/TB/2012.11
   Google Scholar
• National Centre for Disease Control. Biosafety manual for public health laboratories. New Delhi: Directorate General of Health Services Ministry of Health and Family Welfare; 2016. Available from: http://www.ncdc.gov.in/writereaddata/mainlinkfile/File608.pdf
   Google Scholar
• Global Laboratory Initiative. Model TB diagnostic algorithms. Global Laboratory Initiative. 2017. Available from: http://www.stoptb.org/wg/gli/assets/documents/GLI_algorithms.pdf
   Google Scholar
• Shah I, Gupta Y. Role of molecular tests for diagnosis of tuberculosis in children. Pediatric Oncall 2015 (1): 12. http://www.pediatriconcall.com/pediatric-journal/View/fulltext-articles/923/J/0/0/485/0
   Google Scholar
• Sachdeva KS, Raizada N, Sreenivas A, et al. Use of Xpert MTB/RIF in decentralized public health settings and its effect on pulmonary TB and DR-TB case finding in India. Plos One 2015; 10: e0126065
   PubMed Web of Science ®Google Scholar
• Rupert S, Vassall A, Raizada N, et al. Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India. Int J Tuberc Lung Dis 2017; 21(4):375–380.
   PubMed Web of Science ®Google Scholar
• Khaparde S, Raizada N, Nair SA, et al. (2017) Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: an economic analysis. PLoS ONE 12(9): e0184270.
   PubMed Web of Science ®Google Scholar
• Vassall A, van Kampen S, Sohn H, et al. (2011) Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 8(11): e1001120.
   PubMed Web of Science ®Google Scholar
• Shah M, Chihota V, Coetzee G, et al. Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa. BMC Infect Dis 2013; 13:352
   PubMed Web of Science ®Google Scholar
• Bajinka O, Secka O. Integration of molecular methods into microbiological diagnostics. Appli Micro Open Access 2017; 3(1) 130: 1–6.
   Google Scholar
• Pantoja A, Fitzpatrick C, Vassall A, et al. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J 2013 42: 708–720
   PubMed Web of Science ®Google Scholar
• Frick M, Lessem E, McKenna L. Diagnostics, treatment, prevention and vaccines in development (Tuberculosis edition). London: HIV i-Base/Treatment Action Group; 2016.
   Google Scholar